HCV Next: HCV In MSM: An Epidemic with a 'Shocking" Lack of Education

HCV In MSM: An Epidemic with a 'Shocking" Lack of Education

The following articles appeared in the July 2015 print edition of "HCV Next" published online at "Healio."

"HCV Next" offers information on a range of topics, which include diagnosis, new combination therapies, side effects, drug/drug interaction, guidelines, fatty liver disease and more.

Table of Contents
5 QUESTIONS
A Conversation with Catherine T. Frenette, MD

COVER STORY
HCV In MSM: An Epidemic with a 'Shocking" Lack of Education

EDITORIAL
The Physician as the Health Economist: A Necessity of Today

FEATURE
CVD Prevention, Treatment Challenging as Patients With HCV, HIV Live Longer

IN THE JOURNALS
Researchers Discover HCV Prevalent in Sub-Saharan Africa

Statins Improve SVR Rates, Lower Cirrhosis, HCC risk in HCV Therapy

Injection Drug Users Reach SVR with HCV Dual Antiviral Therapy

MEETING NEWS COVERAGE

Grazoprevir/Elbasvir Shows Excellent Activity in Prior Non- Responders

Daclatasvir/Sofosbuvir Effective in HCV Patients with HIV, Cirrhosis

Payer Restrictions Discriminate, Contradict Medical Society Guidance

Analysis Provides Insight on Negative Predictors of SVR12

TREND WATCH

WHO Releases 2015 Essential Medicines List, Including HCV Drugs

Merck Submits New Drug Application for Grazoprevir/Elbasvir for HCV

Public Health Groups sue FDA Over Access to HCV Clinical Trial Data